Sulindac exhibits anti-proliferative and anti-invasive effects in uterine serous carcinoma cells.

Shuning ChenWeimin KongXiaochang ShenBoer DengJennifer HaagNikita SinhaCatherine JohnWenchuan SunChunxiao ZhouVictoria L Bae-Jump

Published in: Journal of cancer research and clinical oncology (2024)

Sulindac is a potential therapeutic agent for USC that deserves further exploration in pre-clinical studies and potentially future clinical trials.

Keyphrases